Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN‐γ‐inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4⁺ T‐cell activation

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1993 • 828 citations

Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

1983 • 701 citations

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex

1996 • 650 citations

Receptor-Mediated Antigen Uptake and its Effect on Antigen Presentation to Class II-Restricted T Lymphocytes

1990 • 605 citations

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA

1997 • 510 citations

REGULATION OF MHC CLASS II GENES: Lessons from a Disease

1996 • 488 citations

Helper T‐Cell Subsets: Phenotype, Function and the Role of Lymphokines in Regulating their Development

1991 • 423 citations

Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death

1996 • 362 citations

Differential Regulation of Murine T Lymphocyte Subsets

1993 • 343 citations

Tumor-Specific CD4+ T Cells Have a Major “Post-Licensing” Role in CTL Mediated Anti-Tumor Immunity

2000 • 337 citations

How MHC Class II Molecules Acquire Peptide Cargo: Biosynthesis and Trafficking through the Endocytic Pathway

1995 • 280 citations

Class II transactivator regulates the expression of multiple genes involved in antigen presentation.

1995 • 267 citations

A new human HLA class II-related locus, DM

1991 • 251 citations

Modulation of T-cell function by gliomas

1991 • 241 citations

Treatment of intracranial gliomas with bone marrow—derived dendritic cells pulsed with tumor antigens

1999 • 239 citations

The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-?, T-cell apoptosis, and the immune privilege of the brain

1995 • 233 citations

Biology and treatment of malignant glioma.

2000 • 210 citations

Immunohistological study of mononuclear cell infiltrate in malignant gliomas

1987 • 192 citations

Two Distinct Gamma Interferon-Inducible Promoters of the Major Histocompatibility Complex Class II Transactivator Gene Are Differentially Regulated by STAT1, Interferon Regulatory Factor 1, and Transforming Growth Factor β

1999 • 184 citations

Antigen conformation determines processing requirements for T-cell activation.

1984 • 181 citations

Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA‐1, Mo‐1 and p!50,95

1985 • 162 citations

Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.

1991 • 159 citations

Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-β, IL-4, IL-13 and IL-10

1999 • 156 citations

Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.

1998 • 156 citations

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.

1997 • 154 citations

Human Glioma-Induced Immunosuppression Involves Soluble Factor(s) That Alters Monocyte Cytokine Profile and Surface Markers

1999 • 140 citations

Identification of Distinct Regions of 5′ Flanking DNA That Mediate Constitutive, IFN-γ, STAT1, and TGF-β-Regulated Expression of the Class II Transactivator Gene

1998 • 131 citations

In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers

1988 • 126 citations

Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.

1996 • 125 citations

Relationship of in Vitro Morphologic and Growth Characteristics of Established Human Glioma-derived Cell Lines to Their Tumorigenicity in Athymic Nude Mice

1981 • 122 citations

Inflammatory infiltrates and natural killer cell presence in human brain tumors

1988 • 121 citations

Cytokine-secreting tumor cell vaccines

2000 • 119 citations

Distinct antigen MHC class II complexes generated by separate processing pathways.

1996 • 115 citations

Biology and treatment of malignant glioma.

2000 • 113 citations

Astrocytes Express Elements of the Class II Endocytic Pathway and Process Central Nervous System Autoantigen for Presentation to Encephalitogenic T Cells

1998 • 112 citations

The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.

1993 • 111 citations

Interleukin-2 gene therapy in a patient with glioblastoma.

1995 • 107 citations

Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo

2000 • 98 citations

Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA.

1990 • 96 citations

Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992

1999 • 94 citations

IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.

1999 • 91 citations

AN IN VITRO SYSTEM FOR THE STUDY OF MYELIN SYNTHESIS¹

1969 • 91 citations

Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance

1998 • 85 citations

Presentation of autoantigen by human T cells.

1991 • 80 citations

Stem cell studies of human malignant brain tumors

1983 • 80 citations

Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis

2000 • 78 citations

Escape of Human Cytomegalovirus from HLA-DR-Restricted CD4⁺T-Cell Response Is Mediated by Repression of Gamma Interferon-Induced Class II Transactivator Expression

1999 • 78 citations

Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells

1992 • 77 citations

Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast

1991 • 75 citations

IFN-γ Regulation of the Type IV Class II Transactivator Promoter in Astrocytes

1999 • 72 citations

Glioblastoma multiforme: Pathology, natural history and treatment

1984 • 69 citations

Constitutive Expression of MHC Class II Genes in Melanoma Cell Lines Results from the Transcription of Class II Transactivator Abnormally Initiated from Its B Cell-Specific Promoter

2001 • 68 citations

CD4+ T-cell subsets: regulation of differentiation and function

1991 • 67 citations

The Shaping of the Brain–Specific T Lymphocyte Repertoire in the Thymus

1996 • 66 citations

Interleukin-12-based Immunotherapy against Rat 9L Glioma

1998 • 58 citations

Effects of γ-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy

1992 • 56 citations

Immunohistochemical Analysis of Infiltrating Lymphocytes in Central Nervous System Tumors

1986 • 55 citations

Reduction of End‐stage Malignant Glioma by Injection with Autologous Cytotoxic T Lymphocytes

1999 • 55 citations

Mononuclear cell infiltration in central portions of human astrocytomas

1988 • 53 citations

Differential selectivity of CIITA promoter activation by IFN-γ and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-α

1999 • 53 citations

Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens.

1983 • 49 citations

Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors

1988 • 47 citations

Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12

1999 • 44 citations

Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset

1999 • 44 citations

Recent advances in immunobiology of brain tumors

1993 • 42 citations

High-Grade Astrocytomas

1995 • 41 citations

Dissection of human allostimulatory determinants with cloned T cells: Stimulation inhibition by monoclonal antibodies TÜ22, 34, 36, 37, 39, 43, and 58 against distinct human MHC class II molecules

1985 • 35 citations

Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells

1990 • 33 citations

Heterogeneity of the Induction of HLA-DR Expression by Human Immune Interferon on Glioma Cell Lines and Their Clones<xref ref-type="fn" rid="FN2">2</xref>

1986 • 32 citations

Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells.

1999 • 22 citations

MHC Class II expression by human glioma cells after in vitro incubation with soluble antigens

2009 • 17 citations

Identification of an interferon-γ-responsive element of a class II major histocompatibility gene in rat type 1 astrocytes

1991 • 9 citations